Vimarsana
Biggest News Aggregation in the World

Page 27 - Sera Prognostics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sera Prognostics Today - Breaking & Trending Today

Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs - Vimarsana News

Sera Prognostics Appoints Woodrow Myers, MD, MBA As Advisor Of Public And Political Affairs

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sera Prognostics Announces Publication of the Clinical Validation of PreTRM® Threshold for Clinical Action - Vimarsana News

Sera Prognostics Announces Publication of the Clinical Validation of PreTRM® Threshold for Clinical Action

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Announces Collaboration To Help Underserved Communities Make Informed Decisions About Prenatal Health - Vimarsana News

Sera Prognostics Announces Collaboration To Help Underserved Communities Make Informed Decisions About Prenatal Health

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
Sera Prognostics Announces Conference Call and Webcast of Third Quarter 2021 Financial Results on November 9 - Vimarsana News

Sera Prognostics Announces Conference Call and Webcast of Third Quarter 2021 Financial Results on November 9

/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...

Sera Prognostics Announces Pricing of Initial Public - Vimarsana News

Sera Prognostics Announces Pricing of Initial Public

Sera Prognostics Announces Pricing of Initial Public Offering July 14, 2021 21:03 ET | Source: Sera Prognostics Sera Prognostics SALT LAKE CITY, July 14, 2021 (GLOBE NEWSWIRE) -- Sera Prognostics Inc., The Pregnancy Company ® (“Sera”), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced the pricing of its initial public offering of 4,687,500 shares of its common stock at a price to the public of $16.00 per share. The gross proceeds to Sera from the offering, before ...